Nyxoah (NYXH) Gains from Sales and Divestitures (2021 - 2026)
Nyxoah (NYXH) posted Gains from Sales and Divestitures of $686955.9 for Q2 2026, down 15.08% on a QoQ basis from $808985.2 in Q1 2026, and up 13.65% year-over-year from $604466.5 in Q2 2025.
Powered by 
Analysis
Nyxoah (NYXH) Gains from Sales and Divestitures (2021 - 2026) Analysis & Trends
Nyxoah has reported Gains from Sales and Divestitures for 6 years, with the latest figure at $686955.9 in Q2 2026.
- On a quarterly basis, Gains from Sales and Divestitures rose 13.65% year-over-year to $686955.9 in Q2 2026; TTM through Jun 2026 was $2.7 million, a 20.56% increase from a year earlier, with the FY2024 full-year figure at $1.9 million, up 25.39% from the prior year.
- Gains from Sales and Divestitures was $686955.9 for Q2 2026 at Nyxoah, down from $808985.2 in the prior quarter.
- The five-year high for Gains from Sales and Divestitures was $808985.2 in Q1 2026, with the low at $286196.1 in Q1 2022.
- Average Gains from Sales and Divestitures over 5 years is $453073.4, with a median of $427123.3 recorded in 2024.
- The sharpest annual moves came in 2022 and 2023: Gains from Sales and Divestitures sank 32.11% in 2022, then jumped 77.11% in 2023.
- Over 5 years, Gains from Sales and Divestitures stood at $292811.0 in 2022, then surged by 77.11% to $518603.0 in 2023, then rose by 5.29% to $546052.2 in 2024, then grew by 10.7% to $604466.5 in 2025, then advanced by 13.65% to $686955.9 in 2026.
- The last three Gains from Sales and Divestitures figures came in at $686955.9 (Q2 2026), $808985.2 (Q1 2026), and $604466.5 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.18 Bn | 173.23 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 142.14 Bn | 137.06 Bn | 1.96 Bn |
| 3 | Medtronic | 117.43 Bn | 109.23 Bn | 6.34 Bn |
| 4 | Stryker | 105.15 Bn | 101.68 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.37 Bn | 63.08 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 50.93 Bn | 46.79 Bn | 1.35 Bn |
| 7 | Dexcom | 33.65 Bn | 31.71 Bn | 830.00 Mn |
| 8 | Resmed | 32.27 Bn | 30.80 Bn | 861.22 Mn |
| 9 | Alcon | 31.62 Bn | 30.17 Bn | 1.68 Bn |
| 10 | Nyxoah | 63.68 Mn | -49.98 Mn | 5.33 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 686,955.86 |
| Mar 31, 2026 | 808,985.24 |
| Jun 30, 2025 | 604,466.47 |
| Mar 31, 2025 | 564,861.94 |
| Dec 31, 2024 | 546,052.25 |
| Sep 30, 2024 | 495,297.00 |
| Jun 30, 2024 | 452,292.78 |
| Mar 31, 2024 | 401,953.85 |
| Dec 31, 2023 | 518,603.04 |
| Sep 30, 2023 | 300,450.97 |
| Jun 30, 2023 | 350,633.65 |
| Mar 31, 2023 | 341,322.70 |
| Dec 31, 2022 | 292,810.99 |
| Sep 30, 2022 | 298,449.20 |
| Jun 30, 2022 | 299,842.93 |
| Mar 31, 2022 | 286,196.12 |
| Dec 31, 2021 | 431,277.05 |
| Sep 30, 2021 | 213,451.01 |
| Jun 30, 2021 | 256,509.82 |
| Mar 31, 2021 | 197,822.72 |
API Access
Nyxoah Gains from Sales and Divestitures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=NYXH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gains-from-sales-and-divestitures", "ticker": "NYXH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=NYXH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();